Standout Papers
- Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial (2010)
- Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials (2015)
- Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis (2016)
Immediate Impact
6 from Science/Nature 120 standout
Citing Papers
Tirzepatide as Compared with Semaglutide for the Treatment of Obesity
2025 Standout
Obesity in adults
2024 Standout
Works of J. Erickson being referenced
Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
2010 Standout
Weight Loss With Naltrexone SR/Bupropion SR Combination Therapy as an Adjunct to Behavior Modification: The COR‐BMOD Trial
2010
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| J. Erickson | 1524 | 1376 | 384 | 985 | 38 | 3.7k | |
| Susan Ball | 1557 | 685 | 950 | 624 | 137 | 5.7k | |
| Olawale Osuntokun | 1474 | 341 | 60 | 406 | 27 | 2.4k | |
| Frank B. Hu | 127 | 1444 | 85 | 1311 | 41 | 5.3k | |
| Robert Wołk | 1260 | 119 | 399 | 2372 | 137 | 6.2k | |
| Walter Futterweit | 293 | 265 | 39 | 291 | 86 | 9.1k | |
| Giovanni Giugliano | 443 | 474 | 29 | 2310 | 21 | 7.0k | |
| Kaitlin H. Wade | 412 | 121 | 158 | 916 | 52 | 6.4k | |
| Yekta Dowlati | 190 | 384 | 321 | 403 | 15 | 4.0k | |
| Elliot Ehrich | 633 | 1769 | 106 | 324 | 49 | 4.2k | |
| Per M. Humpert | 523 | 174 | 108 | 829 | 69 | 4.7k |
All Works
Loading papers...